Ascendis Pharma A/s(ASND)
$137.20
Market is closed - opens 7 PM, 06 May 2024
Insights
- Ascendis Pharma A/s is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ascendis Pharma A/s stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Ascendis Pharma A/s stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Ascendis Pharma A/s stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 45.97 | Neutral |
Stochastic | 45.89, 36.58 | Neutral |
Ultimate Oscillator | 45.44 | Neutral |
Stochastic Relative Strength Index | 67.04, 47.28 | Neutral |
Moving Average Convergence Divergence | -2.17, -1.94 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 140.38 | Sell |
20 | 143.78 | Sell |
50 | 147.25 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 140.84 | Sell |
20 | 142.66 | Sell |
50 | 143.53 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 140.42 | Neutral |
20 | 144.75 | Sell |
50 | 147.75 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 139.15 | Sell |
20 | 139.82 | Sell |
50 | 146.65 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 139.56 | Buy |
20 | 138.24 | Sell |
50 | 141.84 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 150.26 |
Resistance L2 | 146.4 |
Resistance L1 | 143.71 |
Pivot Point | 139.85 |
Support L1 | 137.16 |
Support L2 | 133.3 |
Support L3 | 130.61 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.